Advertisement

Церезим 400 U

Основна информация

  • Търговско наименование:
  • Церезим 400 U (Cerezyme 400 U)
  • дозиране:
  • 400 U x 1; x 5; x 25
  • Лекарствена форма:
  • прах за концентрат за инфузионен разтвор
  • Композиция:
  • прах за концентрат за инфузионен разтвор 400 U x 1; x 5; x 25
  • Използвай за:
  • Хората
  • Вид на лекарството:
  • алопатични наркотици
Advertisement

Документи

Локализация

  • Предлага се в:
  • Церезим 400 U (Cerezyme 400 U)
    България
  • Език:
  • български

Друга информация

Състояние

  • Източник:
  • Изпълнителна агенция по лекарствата - Bulgarian Drug Agency - Bulgaria
  • Последна актуализация:
  • 09-08-2016

Листовка за пациента


1-2-2018

Scientific guideline:  Dronedarone film-coated tablets 400 mg product-specific bioequivalence guidance - First version, adopted

Scientific guideline: Dronedarone film-coated tablets 400 mg product-specific bioequivalence guidance - First version, adopted

This guidance provides product-specific guidance on the demonstration of the dronedarone.

Europe - EFSA - European Food Safety Authority EFSA Journal

4-8-2017

FDA Drug Safety Communication:Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants

FDA Drug Safety Communication:Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in infants

[8-03-2011] The U.S. Food and Drug Administration (FDA) is informing the public that chronic, high doses (400-800 mg/day) of the antifungal drug Diflucan (fluconazole) may be associated with a rare and distinct set of birth defects in infants whose mothers were treated with the drug during the first trimester of pregnancy.

FDA - U.S. Food and Drug Administration

15-6-2017

Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results

Statement from FDA Commissioner Scott Gottlieb, M.D., on the 2016 National Youth Tobacco Survey results

While the latest numbers from the 2016 National Youth Tobacco Survey are encouraging, it is critical that we work to ensure this downward trend continues over the long term across all tobacco products. Every day in the U.S., more than 2,500 youth under the age of 18 smoke their first cigarette and more than 400 youth become daily cigarette smokers. It is also clear from these most recent numbers that youth are continuing to experiment with, or becoming regular users of, a wide range of other tobacco pro...

FDA - U.S. Food and Drug Administration

19-6-2015

Global operation against illicit medicines completed

Global operation against illicit medicines completed

A global medicine operation results in 156 arrests and shutdown of more than 2,400 websites.

Danish Medicines Agency

31-1-2018

Scientific guideline:  Draft ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg product-specific bioequivalence guidance, draft: consultation open

Scientific guideline: Draft ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg product-specific bioequivalence guidance, draft: consultation open

Ledipasvir/sofosbuvir film-coated tablet 90 mg/400 mg product-specific bioequivalence guidance

Europe - EMA - European Medicines Agency

14-12-2017

ANTI-AGING FOUNDATION SPF 15 SHADE 400 (Octinoxate) Emulsion [La Prairie, Inc.]

ANTI-AGING FOUNDATION SPF 15 SHADE 400 (Octinoxate) Emulsion [La Prairie, Inc.]

Updated Date: Dec 14, 2017 EST

US - DailyMed

12-12-2017

SYSTANE (Polyethylene Glycol 400 And Propylene Glycol) Gel [Alcon Laboratories, Inc.]

SYSTANE (Polyethylene Glycol 400 And Propylene Glycol) Gel [Alcon Laboratories, Inc.]

Updated Date: Dec 12, 2017 EST

US - DailyMed

31-10-2017

MUCUS RELIEF (Guaifenesin 400 Mg) Tablet [Advance Pharmaceutical Inc.]

MUCUS RELIEF (Guaifenesin 400 Mg) Tablet [Advance Pharmaceutical Inc.]

Updated Date: Oct 31, 2017 EST

US - DailyMed

30-10-2017

MUCUS RELIEF (Guaifenesin 400 Mg) Tablet [Richmond Pharmaceuticals, Inc.]

MUCUS RELIEF (Guaifenesin 400 Mg) Tablet [Richmond Pharmaceuticals, Inc.]

Updated Date: Oct 30, 2017 EST

US - DailyMed

28-7-2017

Scientific guideline:  Draft dronedarone film-coated tablets 400 mg product-specific bioequivalence guidance - First version, draft: consultation open

Scientific guideline: Draft dronedarone film-coated tablets 400 mg product-specific bioequivalence guidance - First version, draft: consultation open

This document provides product-specific guidance on the demonstration of the bioequivalence of dronedarone film-coated tablets

Europe - EMA - European Medicines Agency

7-6-2017

Cerezyme (Genzyme Europe B.V.)

Cerezyme (Genzyme Europe B.V.)

Cerezyme (Active substance: imiglucerase) - Centralised - Yearly update - Commission Decision (2017)3951 of Wed, 07 Jun 2017

Europe -DG Health and Food Safety

6-6-2017

MUCUS RELIEF (Guaifenesin 400 Mg) Tablet [HealthLife Of USA LLC]

MUCUS RELIEF (Guaifenesin 400 Mg) Tablet [HealthLife Of USA LLC]

Updated Date: Jun 6, 2017 EST

US - DailyMed

29-3-2017

BLINK TEARS (Polyethylene Glycol 400) Solution/ Drops [Abbott Medical Optics Inc.]

BLINK TEARS (Polyethylene Glycol 400) Solution/ Drops [Abbott Medical Optics Inc.]

Updated Date: Mar 29, 2017 EST

US - DailyMed

29-3-2017

BLINK GEL TEARS (Polyethylene Glycol 400) Solution/ Drops [AMO Hangzhou Co., LTD]

BLINK GEL TEARS (Polyethylene Glycol 400) Solution/ Drops [AMO Hangzhou Co., LTD]

Updated Date: Mar 29, 2017 EST

US - DailyMed

29-3-2017

BLINK TEARS (Polyethylene Glycol 400) Solution/ Drops [AMO Hangzhou Co., LTD]

BLINK TEARS (Polyethylene Glycol 400) Solution/ Drops [AMO Hangzhou Co., LTD]

Updated Date: Mar 29, 2017 EST

US - DailyMed

11-3-2017

Bad Diets Tied to 400,000 U.S. Deaths in 2015

Bad Diets Tied to 400,000 U.S. Deaths in 2015

Title: Bad Diets Tied to 400,000 U.S. Deaths in 2015Category: Health NewsCreated: 3/9/2017 12:00:00 AMLast Editorial Review: 3/10/2017 12:00:00 AM

US - MedicineNet

25-2-2017

Over 400,000 Toy Frogs Recalled for Injury Hazard

Over 400,000 Toy Frogs Recalled for Injury Hazard

Title: Over 400,000 Toy Frogs Recalled for Injury HazardCategory: Health NewsCreated: 2/24/2017 12:00:00 AMLast Editorial Review: 2/24/2017 12:00:00 AM

US - MedicineNet

Advertisement